SynCore Biotechnology to attend at 2018 BIO International Convention in Boston, MA
SynCore Biotechnology (SynCoreBio) is pleased to announce that it [...]
SynCore Bio SB04 Dry-AMD in Phase II/III trial
SB04 is an invasive treatment for dry Age-related Macular [...]
SynCore Biotechnology is to Attend ASCO in Chicago, Illinois
SB05 is a paclitaxel component combined with neutral and [...]